Embryonal carcinoma differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
Latest revision as of 15:07, 20 August 2015
|
Embryonal carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Embryonal carcinoma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Embryonal carcinoma differential diagnosis |
|
Risk calculators and risk factors for Embryonal carcinoma differential diagnosis |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Factors
Differing from the other types of testicular cancers, the embryonal carcinoma can have several of the properties of a mal-developed fetus, including cartilage. The main tumor is, on average, 2.5 centimeters long and can also stem out approximately 9 centimeters up the testicular cord. Embryonal carcinomas are usually seen in males age 25-35, but have also hit males as young as their late teens. The chances of an embryonal carcinoma spreading from one testicle to the other are less than 1%. Embryonal carcinomas account for approximately 40% of testicular tumors.
Rarely, embryonal carcinomas are seen in females, in the ovaries.